Skip to content
Free panel check
Case studies

Community intelligence in practice

Real results from engaging populations regulators ask about before protocol lock, when design decisions are still reversible and upstream intelligence delivers the greatest return.

$2.4M–
$4.8M
Estimated value from
timeline compression
Phase II · Biotech
How community intelligence saved a Phase II biotech trial months and millions
A small-to-midsize biotech sponsor engaged Unwritten Health before protocol lock. Recruitment delivered 560 participants of African descent in 12 weeks (12% over target), and upstream interventions compressed a 9–12 month study start-up to a projected 6 months, an estimated $2.4M–$4.8M in direct and commercial value.
6 months
Projected start-up vs. 9–12 benchmark
560 / 500
Participants of African descent in 12 weeks
Phase II
Study phase
Read case study →

More case studies in preparation. We document our work carefully and anonymise where required. If you would like to discuss a specific therapy area or challenge, get in touch directly.

Free panel check.

Tell us who your clinical trial or product is for. We'll tell you, the same day, how many people like that we hold and how they break down.

Check the panelBook 30 minutes with Ashish (opens in a new tab)
Check the panel